Korsana Biosciences, Inc. (KRSA)
30.14
-0.08
(-0.26%)
USD |
NASDAQ |
Oct 30, 16:00
30.13
-0.01
(-0.03%)
After-Hours: 20:00
Korsana Biosciences Free Cash Flow : -4.517M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.517M |
| March 31, 2026 | -3.588M |
| December 31, 2025 | -3.314M |
| September 30, 2025 | -1.375M |
| June 30, 2025 | -2.827M |
| March 31, 2025 | -3.43M |
| December 31, 2024 | -4.333M |
| September 30, 2024 | -6.234M |
| June 30, 2024 | -11.45M |
| March 31, 2024 | -16.90M |
| December 31, 2023 | -21.24M |
| September 30, 2023 | -26.75M |
| June 30, 2023 | -29.73M |
| March 31, 2023 | -33.99M |
| December 31, 2022 | -40.61M |
| September 30, 2022 | -42.20M |
| Date | Value |
|---|---|
| June 30, 2022 | -40.21M |
| March 31, 2022 | -34.90M |
| December 31, 2021 | -36.52M |
| September 30, 2021 | -41.97M |
| June 30, 2021 | -49.10M |
| March 31, 2021 | -57.88M |
| December 31, 2020 | -74.01M |
| September 30, 2020 | -82.28M |
| June 30, 2020 | -91.68M |
| March 31, 2020 | -103.60M |
| December 31, 2019 | -109.10M |
| September 30, 2019 | -111.73M |
| June 30, 2019 | -113.73M |
| March 31, 2019 | -110.44M |
| December 31, 2018 | -100.94M |
| September 30, 2018 | -102.20M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Q32 Bio, Inc. | -19.83M |
| IRulya Therapeutics, Inc. | -47.00M |
| Climb Bio, Inc. | -53.07M |
| PepGen Inc. | -69.46M |
| Bridgebio Oncology Therapeutics, Inc. | -193.82M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.432M |
| Free Cash Flow Per Share (Quarterly) | -2.358 |
| Free Cash Flow to Equity (Quarterly) | -1.432M |
| Free Cash Flow to Firm (Quarterly) | -1.432M |
| Free Cash Flow Yield | -27.07% |